z-logo
Premium
Nonspecific CD4 + T cells with uptake of antigen‐specific dendritic cell‐released exosomes stimulate antigen‐specific CD8 + CTL responses and long‐term T cell memory
Author(s) -
Hao Siguo,
Yuan Jinying,
Xiang Jim
Publication year - 2007
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.0407249
Subject(s) - cd80 , biology , cytotoxic t cell , t cell , cd40 , dendritic cell , cd8 , antigen presenting cell , microbiology and biotechnology , immune system , microvesicles , ctl* , antigen , immunology , priming (agriculture) , in vitro , biochemistry , microrna , botany , germination , gene
Dendritic cell (DC) and DC‐derived exosomes (EXO) have been used extensively for tumor vaccination. However, its therapeutic efficiency is limited to only production of prophylactic immunity against tumors. T cells can uptake DC‐released EXO. However, the functional effect of transferred exosomal molecules on T cells is unclear. In this study, we demonstrated that OVA protein‐pulsed DC‐derived EXO (EXO OVA ) can be taken up by Con A‐stimulated, nonspecific CD4 + T cells derived from wild‐type C57BL/6 mice. The active EXO‐uptaken CD4 + T cells (aT EXO ), expressing acquired exosomal MHC I/OVA I peptide (pMHC I) complexes and costimulatory CD40 and CD80 molecules, can act as APCs capable of stimulating OVA‐specific CD8 + T cell proliferation in vitro and in vivo and inducing efficient CD4 + Th cell‐independent CD8 + CTL responses in vivo. The EXO OVA ‐uptaken CD4 + aT EXO cell vaccine induces much more efficient CD8 + T cell responses and immunity against challenge of OVA‐transfected BL6‐10 melanoma cells expressing OVA in wild‐type C57BL/6 mice than EXO OVA . The in vivo stimulatory effect of the CD4 + aT EXO cell to CD8 + T cell responses is mediated and targeted by its CD40 ligand signaling/acquired exosomal CD80 and pMHC I complexes, respectively. In addition, CD4 + aT EXO vaccine stimulates a long‐term, OVA‐specific CD8 + T cell memory. Therefore, the EXO OVA ‐uptaken CD4 + T cells may represent a new, effective, EXO‐based vaccine strategy in induction of immune responses against tumors and other infectious diseases.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here